![Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile](https://i1.rgstatic.net/ii/profile.image/272305800609808-1441934170704_Q512/Emeline-Tabouret.jpg)
Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile
![The GlioME team has obtained a "Action Structurante" funding for the creation of the PETRA facility | Institut de neurophysiopathologie - UMR 7051 The GlioME team has obtained a "Action Structurante" funding for the creation of the PETRA facility | Institut de neurophysiopathologie - UMR 7051](https://inp.univ-amu.fr/sites/inp.univ-amu.fr/files/resize/article/petra-872x492.png)
The GlioME team has obtained a "Action Structurante" funding for the creation of the PETRA facility | Institut de neurophysiopathologie - UMR 7051
![Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile](https://www.researchgate.net/publication/373102112/figure/fig1/AS:11431281182762117@1692504305143/Functional-validation-of-top-gene-hit-RRM1-in-glioblastoma-cells-and-patient-samples-a_Q320.jpg)
Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile
![The GlioME team has obtained a "Action Structurante" funding for the creation of the PETRA facility | Institut de neurophysiopathologie - UMR 7051 The GlioME team has obtained a "Action Structurante" funding for the creation of the PETRA facility | Institut de neurophysiopathologie - UMR 7051](https://inp.univ-amu.fr/sites/inp.univ-amu.fr/files/article/petra_et-at-tv.png)
The GlioME team has obtained a "Action Structurante" funding for the creation of the PETRA facility | Institut de neurophysiopathologie - UMR 7051
![PDF) Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome PDF) Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome](https://i1.rgstatic.net/publication/327513021_Somatostatin_receptor_2A_protein_expression_characterizes_anaplastic_oligodendrogliomas_with_favorable_outcome/links/5b92b6ea299bf1473922daeb/largepreview.png)
PDF) Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
![Dr. Emeline Tabouret (GlioME team) in collaboration with Dr. Rafael Arguello (CIML Institute) published a new paper in Cell metabolism journal | Institut de neurophysiopathologie - UMR 7051 Dr. Emeline Tabouret (GlioME team) in collaboration with Dr. Rafael Arguello (CIML Institute) published a new paper in Cell metabolism journal | Institut de neurophysiopathologie - UMR 7051](https://inp.univ-amu.fr/sites/inp.univ-amu.fr/files/article/scenith_graphical-abstract.jpg)
Dr. Emeline Tabouret (GlioME team) in collaboration with Dr. Rafael Arguello (CIML Institute) published a new paper in Cell metabolism journal | Institut de neurophysiopathologie - UMR 7051
![Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile](https://www.researchgate.net/publication/357671724/figure/fig1/AS:1126119331893262@1645499179817/Cerebral-MRI-of-a-patient-with-thalamic-glioma-A-contrast-enhanced-T1-weighted-images_Q320.jpg)
Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile
![Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile Emeline TABOURET | Neuro-Oncology, APHM, Timone Hospital, 13005, Marseille | MD PhD | Aix-Marseille Université, Marseille | AMU | aix-marseille university | Research profile](https://www.researchgate.net/publication/372483403/figure/fig1/AS:11431281175842729@1689894675046/Absence-of-modification-of-transcriptomic-signature-and-epigenetic-signature-after_Q320.jpg)